Comparison of antiemetic efficacy of domperidone, metoclopramide, and dexamethasone in patients receiving outpatient chemotherapy regimens

25Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Nausea and vomiting during treatment with cytotoxic drugs lead to appreciable morbidity and in one study were considered to be the worst symptoms of chemotherapy. Several antiemetic regimens have been developed to combat this problem, but many are either not totally effective or associated with appreciable toxicity, such as drowsiness and dryness of the mouth. Metoclopramide, dexamethasone, and domperidone are widely used in clinical practice, but so far there has been no randomised trial to investigate which is most effective. © 1987, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Cunningham, D., Evans, C., Gazet, J. claude, Ford, H., Pople, A., Dearling, J., … Coombes, C. (1987). Comparison of antiemetic efficacy of domperidone, metoclopramide, and dexamethasone in patients receiving outpatient chemotherapy regimens. British Medical Journal (Clinical Research Ed.), 295(6592), 250. https://doi.org/10.1136/bmj.295.6592.250

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free